Skip to content
Orphan drugs are the fastest-growing segment of the pharmaceutical market, but the Inflation Reduction Act (IRA) clouds the future of new treatments for rare […]
Report sees booming orphan drug market threatened by price controls Read More »
Polls conducted by YouGov and Wakefield Research show the majority of Americans want the government to invest in better pandemic preparedness in the wake
Polls show Americans want better pandemic preparedness Read More »
On April 3, the Biden administration released a National Cancer Plan that seeks to coordinate government, research, and the biotech industry to cut cancer deaths
National Cancer Plan outlines government cooperation with biotech industry Read More »
The “benefits” pharmacy benefit managers (PBMs) once provided have been lost, as these organizations now mostly help themselves while driving up drug prices, said
Senate hearing looks at what went wrong with PBMs Read More »
The threat of expanding intellectual property waivers by the World Trade Organization (WTO) dampens investment in research, Biotechnology Innovation Organization’s (BIO) Chief Policy Officer
BIO opposes extension of WTO IP waiver in federal hearing Read More »
The lessons of COVID-19 were unequivocal: Pandemic preparedness is key to national security. According to a national poll conducted by the Biotechnology Innovation Organization
Voters want better pandemic preparedness Read More »
The impact of drug price controls on innovation, market distortions caused by pharmacy benefit managers (PBMs), and the importance of accelerated approval came up
House 2024 health budget hearings touch on price controls and PBMs Read More »
The Council of State Bioscience Associations (CSBA), a coalition of state-based bioscience trade associations convened by the Biotechnology Innovation Organization (BIO), joined forces in
CSBA hits Capitol Hill for face time with lawmakers Read More »
Legislation that has been reintroduced in the Senate and has the support of the Biotechnology Innovation Organization (BIO) is set to enhance research, an
R&D in biotech gets a boost with reintroduced bill Read More »
The Department of Health and Human Services (HHS) and Department of Commerce (DOC) will investigate using Bayh-Dole march-in rights as a way to control
HHS investigating using Bayh-Dole march-in rights for price controls Read More »
